• CD4/CD8 Lymphocyte Ratio
  • Fluconazole, Urine
  • B-Cell Lymphoma, FISH, Tissue
  • 17-Hydroxypregnenolone, Serum
  • Coxsackie A Virus Antibodies, CSF
  • Septin 9 (SEPT9) Gene Mutation Analysis
  • Toxoplasma IgM
  • Phospholamban (PLN) Gene Mutation Analysis
  • Ganglioside (Asialo-GM1, GM1, GM2, GD1a, GD1b, and GQ1b) Antibodies
  • Microsatellite Instability (MSI), HNPCC/Lynch Syndrome
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Complement Component CH50
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Complement Component CH50
Medical Test

Clinical Utility
Access to Complement Component CH50 is restricted.